PuSH - Publikationsserver des Helmholtz Zentrums München

Mollberg, N.M.* ; Steinert, G.* ; Aigner, M.* ; Hamm, A.* ; Lin, F.J.* ; Elbers, H.* ; Reissfelder, C.* ; Weitz, J.* ; Büchler, M.W.* ; Koch, M.*

Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse.

Cancer Biol. Ther. 13, 694-700 (2012)
DOI PMC Verlagsversion bestellen
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The non-ABC transport protein RalBP1 has been shown to be overexpressed in various cancer cell lines and implicated in the process of metastasis formation, but its expression in tissue samples and prognostic significance has not been shown. In this study matched tumor-mucosa tissue samples from 78 CRC patients were investigated. The RalBP1 mRNA and protein levels were quantified by real-time quantitative PCR (qPCR) and ELISA. RalBP1 was found to be overexpressed in tumor at the mRNA level both overall (p = 0.027), and for stages I (p = 0.024), II (p = 0.038) and IV (p = 0.004). At the protein level, RalBP1 was only significantly overexpressed in stage IV patients (p = 0.018). Expression of RalBP1 mRNA and protein were inversely correlated (r = 0.4173; p = 0.0004). Multivariate Cox regression analysis including sex, age, stage, grade, and nodal status as covariates showed that overexpression of RalBP1 protein, but not mRNA, was an independent predictor of both decreased disease free survival (p = 0.016, RR = 6.892) and overall survival (p = 0.039, RR = 5.986). These results suggest that RalBP1 protein is an independent predictor of poor survival and early relapse for CRC patients. Owing to its multifunctional intermediary role in cell survival, chemotherapeutic resistance, and metastasis formation, RalBP1 represents a promising novel therapeutic target.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
ISSN (print) / ISBN 1538-4047
e-ISSN 1555-8576
Zeitschrift Cancer Biology & Therapy
Quellenangaben Band: 13, Heft: 8, Seiten: 694-700 Artikelnummer: , Supplement: ,
Verlag Landes Bioscience
Begutachtungsstatus
Institut(e) Institute for Pancreatic Beta Cell Research (IPI)